Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio

MeSH terms

• Aged
• Clostridioides difficile*
• Clostridium Infections* / diagnosis
• Clostridium Infections* / immunology
• Clostridium Infections* / microbiology
• Clostridium Infections* / therapy
• Fecal Microbiota Transplantation* / adverse effects
• Female
• Humans
• Immunocompromised Host*
• Male
• Middle Aged
• Recurrence
• Risk Assessment
• Treatment Outcome